Notice of Proposed Sale · 144
Tempus AI, Inc.
TEMNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- TEMPUS AI, INC.
- Issuer CIK
- 0001717115
- SEC file number
- 001-42130
- Phone
- 800-976-5448
- Person for whose account securities are to be sold
- Ryan Fukushima
- Relationships to issuer
- Officer
- Street
- 600 WEST CHICAGO AVENUE, SUITE 510
- City
- CHICAGO
- State / country code
- IL
- Postal code
- 60654
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Class A Common Stock | 41,095 | 2,122,145.8 | 175,390,967 | 08/18/2026 | NASDAQ | Morgan Stanley Smith Barney LLC Executive Financial Services |
Broker / market maker — proposed row 1, entry 1
- Name
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Street
- 1 New York Plaza, 8th Floor
- City
- New York
- State / country code
- NY
- Postal code
- 10004
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | 01/03/2022 | Restricted Stock Units | Issuer | 1,730 | N | 01/03/2022 | N/A |
| Class A Common Stock | 04/18/2023 | Restricted Stock Units | Issuer | 577 | N | 04/18/2023 | N/A |
| Class A Common Stock | 07/18/2023 | Restricted Stock Units | Issuer | 5,765 | N | 07/18/2023 | N/A |
| Class A Common Stock | 08/01/2024 | Restricted Stock Units | Issuer | 2,307 | N | 08/01/2024 | N/A |
| Class A Common Stock | 08/07/2026 | Performance Stock Units | Issuer | 30,716 | N | 08/07/2026 | N/A |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| 10b5-1 Sales for VANESSA KUBO | Class A Common Stock | 08/07/2026 | 20,000 | 1,000,815.13 |
| 10b5-1 Sales for VANESSA KUBO | Class A Common Stock | 08/03/2026 | 23,818 | 1,100,036.71 |
| 10b5-1 Sales for VANESSA KUBO | Class A Common Stock | 07/08/2026 | 33,284 | 1,910,172.09 |
| 10b5-1 Sales for VANESSA KUBO | Class A Common Stock | 07/06/2026 | 10,000 | 600,000.00 |
Seller — prior-sale row 1, entry 1
- Name
- 10b5-1 Sales for VANESSA KUBO
- Street
- 600 West Chicago Avenue, Suite 510
- City
- Chicago
- State / country code
- IL
- Postal code
- 60654
Seller — prior-sale row 2, entry 1
- Name
- 10b5-1 Sales for VANESSA KUBO
- Street
- 600 West Chicago Avenue, Suite 510
- City
- Chicago
- State / country code
- IL
- Postal code
- 60654
Seller — prior-sale row 3, entry 1
- Name
- 10b5-1 Sales for VANESSA KUBO
- Street
- 600 West Chicago Avenue, Suite 510
- City
- Chicago
- State / country code
- IL
- Postal code
- 60654
Seller — prior-sale row 4, entry 1
- Name
- 10b5-1 Sales for VANESSA KUBO
- Street
- 600 West Chicago Avenue, Suite 510
- City
- Chicago
- State / country code
- IL
- Postal code
- 60654
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Remarks
The sales reported on this Form 144 are mandated by the Issuer's election under its equity incentive plan to require the satisfaction of a tax withholding obligation to be funded by sell to cover transactions and do not represent discretionary trades by the reporting person.
Notice signature
- Notice date
- 08/19/2026
- Signed
- /s/ Ryan Fukushima
Company context
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.